Key takeaways
Duetact (pioglitazone / glimepiride) and Baqsimi (glucagon) are both medications used to manage blood sugar levels in people with diabetes, but they serve different purposes and belong to different medication classes. Duetact is a combination of a thiazolidinedione and a sulfonylurea, used to treat Type 2 diabetes by helping your body use insulin better and releasing more insulin. It is taken orally once a day with the first main meal. Baqsimi, on the other hand, is an anti-hypoglycemic medication used as a nasal spray to quickly raise blood sugar during severe hypoglycemia (low blood sugar) emergencies. Duetact can cause side effects like weight gain, low blood sugar, and swelling, and it may interact with medications like gemfibrozil (Lopid). Baqsimi can cause side effects such as watery eyes and a stuffy nose, and it should not be used if you have certain tumors like pheochromocytoma or insulinoma. While Duetact is used for ongoing blood sugar management, Baqsimi is for emergency use when blood sugar drops too low.
